Improved outcome in patients with acute myelogenous leukaemia post high-dose chemotherapy with the combination of BCNU, cytarabine, melphalan and autologous haematopoietic cell transplantation

被引：0
|
作者：
Sakellari, I. [1 ]
Mallouri, D. [1 ]
Apostolou, C. [1 ]
Antoniou, A. [1 ]
Batsis, I. [1 ]
Kaloyannidis, P. [1 ]
Kelaidi, C. [1 ]
Tsimperis, S. [1 ]
Smias, C. [1 ]
Papaioannou, G. [1 ]
Sotiropoulos, D. [1 ]
Dourvas, G. [1 ]
Saloum, R. [1 ]
Anagnostopoulos, A. [1 ]
Fassas, A. [1 ]
机构：
[1] G Papanicolaou Hosp, Thessaloniki, Greece
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S275 / S275
页数：1
相关论文
共 50 条
  • [41] Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis
    Perz, JB
    Rahemtulla, A
    Giles, C
    Szydlo, RM
    Davis, J
    Gopaul, D
    Gillmore, J
    Mathias, CJ
    Hawkins, PN
    Apperley, JF
    BONE MARROW TRANSPLANTATION, 2006, 37 (10) : 937 - 943
  • [42] Results of high-dose chemotherapy with autologous haematopoietic stem cell transplantation in the treatment of paediatric brain tumours
    Gevorgian, G.
    Morozova, E.
    Kazantsev, I.
    Iukhta, T.
    Safonova, S.
    Punanov, Y.
    Goloschapov, O.
    Estrina, M.
    Babenko, E.
    Shiriaev, S.
    Zubarovskaya, L.
    Zeludkova, O.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S217 - S217
  • [43] Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis
    J B Perz
    A Rahemtulla
    C Giles
    R M Szydlo
    J Davis
    D Gopaul
    J Gillmore
    C J Mathias
    P N Hawkins
    J F Apperley
    Bone Marrow Transplantation, 2006, 37 : 937 - 943
  • [44] High-dose idarubicin and busulphan as conditioning to autologous stem cell transplantation in adult patients with acute myeloid leukaemia
    Ferrara, F
    Palmieri, S
    De Simone, M
    Sagristani, M
    Viola, A
    Pocali, B
    Fasanaro, A
    Mele, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (02) : 234 - 241
  • [45] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Alexandra Gomez-Arteaga
    Tomer M. Mark
    Danielle Guarneri
    Paul J. Christos
    Usama Gergis
    June D. Greenberg
    Jingmei Hsu
    Sebastian A. Mayer
    Ruben Niesvizky
    Roger N. Pearse
    Adrienne A. Phillips
    Adriana Rossi
    Morton Coleman
    Koen van Besien
    Tsiporah B. Shore
    Bone Marrow Transplantation, 2019, 54 : 2027 - 2038
  • [46] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Gomez-Arteaga, Alexandra
    Mark, Tomer M.
    Guarneri, Danielle
    Christos, Paul J.
    Gergis, Usama
    Greenberg, June D.
    Hsu, Jingmei
    Mayer, Sebastian A.
    Niesvizky, Ruben
    Pearse, Roger N.
    Phillips, Adrienne A.
    Rossi, Adriana
    Coleman, Morton
    van Besien, Koen
    Shore, Tsiporah B.
    BONE MARROW TRANSPLANTATION, 2019, 54 (12) : 2027 - 2038
  • [47] LONG-TERM OUTCOME OF HIGH-DOSE CYTARABINE-BASED CONSOLIDATION CHEMOTHERAPY FOR ADULTS WITH ACUTE MYELOGENOUS LEUKEMIA
    SCHILLER, G
    GAJEWSKI, J
    TERRITO, M
    NIMER, S
    LEE, M
    BELIN, T
    CHAMPLIN, R
    BLOOD, 1992, 80 (12) : 2977 - 2982
  • [48] Outcome of high-dose chemotherapy and autologous haematopoietic stem cell transplantation in children with high-risk primary central nervous system tumour
    Kwon, S. Y.
    Won, S. C.
    Kim, H. S.
    Lyu, C. J.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S229 - S229
  • [49] Tandem high-dose chemotherapy with thiotepa and busulfan–melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients
    C Pasqualini
    C Dufour
    G Goma
    M-A Raquin
    V Lapierre
    D Valteau-Couanet
    Bone Marrow Transplantation, 2016, 51 : 227 - 231
  • [50] Rationale for high-dose chemotherapy and application of haematopoietic growth factors in acute myeloid leukaemia
    Hiddemann, W
    Buchner, T
    ANNALS OF ONCOLOGY, 1995, 6 : 27 - 31
12345